Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • ACT Tulsa
  • Contact

News

Chinese company acquires Cytovance Biologics

By admin | Entrepreneur, News | Comments are Closed | 25 August, 2015 | 0

Cytovance Biologics Inc., an Oklahoma City-based pharmaceutical contract manufacturer, will be acquired by a unit of a Chinese company in a $206 million deal, the companies announced Monday.

i2E-300dpi-Trans-Light
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
Click HERE for printable map with directions.

Tulsa Office

100 S. Cincinnati Ave – 5th Floor, Suite 514
Tulsa, OK 74103
PHONE 918/582-5592
Copyright 2022 i2E, Inc. | All Rights Reserved
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
    • ACT Tulsa
  • e3
  • Concept Fund
  • Portfolio
  • iMCI
  • ACT Tulsa
  • Contact
i2E